Immunotherapy in Treating Patients With Metastatic Breast Cancer

Summary

RATIONALE: Immunotherapy using CEA-treated white blood cells may help a person's body build an immune response to and kill their tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of immunotherapy with CEA-treated white blood cells in treating patients with metastatic breast cancer who have achieved a partial or complete response after chemotherapy and peripheral stem cell transplantation.

Timeline

Start

1998-06

Primary completion

2002-11

Completion

2002-11

Outcome

Outcome not reported

Stopped (Enrollment): “low accrual”

Drugs

Indications